Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Role of (pro)renin receptor in Ang II-mediated EGF receptor transactivation.

Shibayama Y, Hitomi H, Nakano D, Kobori H, Mori H, Deguchi K, Masaki T, Ichihara A, Nishiyama A.

Front Biosci (Elite Ed). 2013 Jan 1;5:697-705.

2.

Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.

Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, Catt KJ.

Mol Endocrinol. 2004 Aug;18(8):2035-48. Epub 2004 May 13.

PMID:
15143154
4.

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.

Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, Dechend R, Fiebeler A, Burckle C, Contrepas A, Jan Danser AH, Bader M, Nguyen G, Luft FC, Muller DN.

Hypertension. 2008 Mar;51(3):682-8. doi: 10.1161/HYPERTENSIONAHA.107.101444. Epub 2008 Jan 22.

5.

Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor.

Murasawa S, Mori Y, Nozawa Y, Gotoh N, Shibuya M, Masaki H, Maruyama K, Tsutsumi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Iwasaka T, Inada M, Matsubara H.

Circ Res. 1998 Jun 29;82(12):1338-48.

6.

Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.

Sakoda M, Ichihara A, Kurauchi-Mito A, Narita T, Kinouchi K, Murohashi-Bokuda K, Saleem MA, Nishiyama A, Suzuki F, Itoh H.

Am J Hypertens. 2010 May;23(5):575-80. doi: 10.1038/ajh.2009.273. Epub 2010 Jan 14.

PMID:
20075844
8.

Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.

Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Murasawa S, Mori Y, Kosaki A, Maruyama K, Masaki H, Shibasaki Y, Fujiyama S, Nose A, Iba O, Hasagawa T, Tateishi E, Higashiyama S, Iwasaka T.

Kidney Int. 2001 Dec;60(6):2153-63.

9.

(Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells.

Peng H, Li W, Seth DM, Nair AR, Francis J, Feng Y.

PLoS One. 2013;8(3):e58339. doi: 10.1371/journal.pone.0058339. Epub 2013 Mar 14.

11.

cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.

Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA, Alexander RW.

Circ Res. 2005 Oct 14;97(8):829-36. Epub 2005 Sep 8. Retraction in: Circ Res. 2010 Jun 11;106(11):1784.

12.

Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells.

Andresen BT, Linnoila JJ, Jackson EK, Romero GG.

Hypertension. 2003 Mar;41(3 Pt 2):781-6. Epub 2003 Jan 6.

17.

Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.

Olivares-Reyes JA, Shah BH, Hernández-Aranda J, García-Caballero A, Farshori MP, García-Sáinz JA, Catt KJ.

Mol Pharmacol. 2005 Aug;68(2):356-64. Epub 2005 May 19.

18.

Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.

Liu HW, Cheng B, Yu WL, Sun RX, Zeng D, Wang J, Liao YX, Fu XB.

Life Sci. 2006 Jun 27;79(5):475-83. Epub 2006 Mar 7.

PMID:
16522324
20.

Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.

Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T.

J Biol Chem. 1998 Apr 10;273(15):8890-6.

Supplemental Content

Support Center